Abstract
As cannabinoid use expands, there grows a need to evaluate cannabidiol (CBD) and cannabinol (CBN) for toxicity potential. This study set out to meet this need using the Emulate human Quad-Culture Liver-Chip to evaluate these two compounds for hepatotoxicity potential.